Testing Trametinib and Dabrafenib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol H)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Janssen Research & Development, LLC
Caribou Biosciences, Inc.
University College Cork
Cedars-Sinai Medical Center
Baylor College of Medicine
Cancer Research UK
University of Miami
M.D. Anderson Cancer Center
City of Hope Medical Center
UNC Lineberger Comprehensive Cancer Center
Medical College of Wisconsin
Brown University
VA Office of Research and Development
Centre Hospitalier Régional d'Orléans